trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Coronary Artery Disease D003324 47 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Translocation, Genetic D014178 20 associated lipids
Cardiomegaly D006332 31 associated lipids
Leukemia, T-Cell D015458 23 associated lipids
Radiation Injuries D011832 14 associated lipids
Leishmaniasis D007896 19 associated lipids
Enteritis D004751 8 associated lipids
Primary Myelofibrosis D055728 6 associated lipids
Fetal Growth Retardation D005317 9 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Wee G et al. Inheritable histone H4 acetylation of somatic chromatins in cloned embryos. 2006 J. Biol. Chem. pmid:16371357
Hsu MC et al. HER-2/neu represses the metastasis suppressor RECK via ERK and Sp transcription factors to promote cell invasion. 2006 J. Biol. Chem. pmid:16377629
Majumder S et al. Epigenetic regulation of metallothionein-i gene expression: differential regulation of methylated and unmethylated promoters by DNA methyltransferases and methyl CpG binding proteins. 2006 J. Cell. Biochem. pmid:16329111
Kurschat P et al. Neuron restrictive silencer factor NRSF/REST is a transcriptional repressor of neuropilin-1 and diminishes the ability of semaphorin 3A to inhibit keratinocyte migration. 2006 J. Biol. Chem. pmid:16330548
Zhou H et al. Epigenetic allele silencing unveils recessive RYR1 mutations in core myopathies. 2006 Am. J. Hum. Genet. pmid:17033962
Suzuki M et al. Site-specific DNA methylation by a complex of PU.1 and Dnmt3a/b. 2006 Oncogene pmid:16331260
Ooi L et al. BRG1 chromatin remodeling activity is required for efficient chromatin binding by repressor element 1-silencing transcription factor (REST) and facilitates REST-mediated repression. 2006 J. Biol. Chem. pmid:17023429
Fan J et al. [Expression of ER alpha in chemically induced MDA-MB-435 cells and its responsiveness to endocrine]. 2006 Zhonghua Zhong Liu Za Zhi pmid:17533736
Gaymes TJ et al. Histone deacetylase inhibitors (HDI) cause DNA damage in leukemia cells: a mechanism for leukemia-specific HDI-dependent apoptosis? 2006 Mol. Cancer Res. pmid:16877702
de Boer J et al. Inhibition of histone acetylation as a tool in bone tissue engineering. 2006 Tissue Eng. pmid:17518660
Malone CS et al. B29 gene silencing in pituitary cells is regulated by its 3' enhancer. 2006 J. Mol. Biol. pmid:16920149
Herman D et al. Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia. 2006 Nat. Chem. Biol. pmid:16921367
Takahashi K et al. Homozygous deletion and reduced expression of the DOCK8 gene in human lung cancer. 2006 Int. J. Oncol. pmid:16391785
Topark-Ngarm A et al. CTIP2 associates with the NuRD complex on the promoter of p57KIP2, a newly identified CTIP2 target gene. 2006 J. Biol. Chem. pmid:16950772
Bai T et al. A novel mechanism for acquired cisplatin-resistance: suppressed translation of death-associated protein kinase mRNA is insensitive to 5-aza-2'-deoxycitidine and trichostatin in cisplatin-resistant cervical squamous cancer cells. 2006 Int. J. Oncol. pmid:16391806
Li Y et al. A novel histone deacetylase pathway regulates mitosis by modulating Aurora B kinase activity. 2006 Genes Dev. pmid:16980585
Minetti GC et al. Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors. 2006 Nat. Med. pmid:16980968
Ohnishi K [Therapeutic strategies for patients with relapsed acute promyelocytic leukemia]. 2006 Rinsho Ketsueki pmid:16986710
Baek SY et al. Trichostatin A increases the thermosensitivity of human glioblastoma A172 cells. 2006 Neurosci. Lett. pmid:16384639
Bates EA et al. Differential contributions of Caenorhabditis elegans histone deacetylases to huntingtin polyglutamine toxicity. 2006 J. Neurosci. pmid:16525063
Chuang HC et al. Histone deacetylase 3 binds to and regulates the GCMa transcription factor. 2006 Nucleic Acids Res. pmid:16528103
Hsiao CH et al. Fetal hemoglobin induction by histone deacetylase inhibitors involves generation of reactive oxygen species. 2006 Exp. Hematol. pmid:16543060
Yamamoto G et al. Correlation of invasion and metastasis of cancer cells, and expression of the RAD21 gene in oral squamous cell carcinoma. 2006 Virchows Arch. pmid:16416296
Yang QC et al. Inhibition of hypoxia-induced angiogenesis by trichostatin A via suppression of HIF-1a activity in human osteosarcoma. 2006 J. Exp. Clin. Cancer Res. pmid:17310851
D'Andrea M et al. Protein kinase C theta co-operates with calcineurin in the activation of slow muscle genes in cultured myogenic cells. 2006 J. Cell. Physiol. pmid:16419034
Akiyama T et al. Inadequate histone deacetylation during oocyte meiosis causes aneuploidy and embryo death in mice. 2006 Proc. Natl. Acad. Sci. U.S.A. pmid:16651529
Hernandez M et al. A histone deacetylation-dependent mechanism for transcriptional repression of the gap junction gene cx43 in prostate cancer cells. 2006 Prostate pmid:16652385
Uchida H et al. Human endometrial cytodifferentiation by histone deacetylase inhibitors. 2006 Hum. Cell pmid:16643606
Stefanovsky V and Moss T Regulation of rRNA synthesis in human and mouse cells is not determined by changes in active gene count. 2006 Cell Cycle pmid:16582637
Wang Q et al. Histone deacetylation is required for orderly meiosis. 2006 Cell Cycle pmid:16582639
Tsuji H et al. Dynamic and reversible changes in histone H3-Lys4 methylation and H3 acetylation occurring at submergence-inducible genes in rice. 2006 Plant Cell Physiol. pmid:16774928
Kwon O et al. NF-kappaB inhibition increases chemosensitivity to trichostatin A-induced cell death of Ki-Ras-transformed human prostate epithelial cells. 2006 Carcinogenesis pmid:16774937
Zhao YM et al. Effects of histone deacetylase inhibitors on transcriptional regulation of the hsp70 gene in Drosophila. 2006 Cell Res. pmid:16775628
Sharma D et al. Restoration of tamoxifen sensitivity in estrogen receptor-negative breast cancer cells: tamoxifen-bound reactivated ER recruits distinctive corepressor complexes. 2006 Cancer Res. pmid:16778215
Sato TA and Mitchell MD Molecular inhibition of histone deacetylation results in major enhancement of the production of IL-1beta in response to LPS. 2006 Am. J. Physiol. Endocrinol. Metab. pmid:16234266
Wu Y and Guo SW Inhibition of proliferation of endometrial stromal cells by trichostatin A, RU486, CDB-2914, N-acetylcysteine, and ICI 182780. 2006 Gynecol. Obstet. Invest. pmid:16778450
Iacomino G et al. Effects of histone deacetylase inhibitors on p55CDC/Cdc20 expression in HT29 cell line. 2006 J. Cell. Biochem. pmid:16795040
Vanniasinkam T et al. Trichostatin-A enhances adaptive immune responses to DNA vaccination. 2006 J. Clin. Virol. pmid:16765083
Li GC et al. Histone deacetylase inhibitor trichostatin A inhibits the growth of bladder cancer cells through induction of p21WAF1 and G1 cell cycle arrest. 2006 Int. J. Urol. pmid:16771729
Zhou C et al. Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells. 2006 Int. J. Oncol. pmid:16773209
Zampetaki A et al. TLR4 expression in mouse embryonic stem cells and in stem cell-derived vascular cells is regulated by epigenetic modifications. 2006 Biochem. Biophys. Res. Commun. pmid:16814255
Jüngel A et al. Trichostatin A sensitises rheumatoid arthritis synovial fibroblasts for TRAIL-induced apoptosis. 2006 Ann. Rheum. Dis. pmid:16284094
Sestáková B and Vachtenheim J Distinct co-regulation of endogenous versus transfected MITF-dependent tyrosinase promoter. 2006 Folia Biol. (Praha) pmid:17116288
Balasubramaniyan V et al. Effects of histone deacetylation inhibition on neuronal differentiation of embryonic mouse neural stem cells. 2006 Neuroscience pmid:17084985
Zhang Y et al. Phosphatidylinositol 3-kinase/protein kinase Czeta-induced phosphorylation of Sp1 and p107 repressor release have a critical role in histone deacetylase inhibitor-mediated derepression [corrected] of transcription of the luteinizing hormone receptor gene. 2006 Mol. Cell. Biol. pmid:16943418
El-Zawahry A et al. In vitro efficacy of AdTRAIL gene therapy of bladder cancer is enhanced by trichostatin A-mediated restoration of CAR expression and downregulation of cFLIP and Bcl-XL. 2006 Cancer Gene Ther. pmid:16167063
Yu Z and Kone BC Targeted histone H4 acetylation via phosphoinositide 3-kinase- and p70s6-kinase-dependent pathways inhibits iNOS induction in mesangial cells. 2006 Am. J. Physiol. Renal Physiol. pmid:16174862
Mühlisch J et al. Epigenetic repression of RASSF1A but not CASP8 in supratentorial PNET (sPNET) and atypical teratoid/rhabdoid tumors (AT/RT) of childhood. 2006 Oncogene pmid:16186793
Lee JH et al. Histone deacetylase inhibitor enhances 5-fluorouracil cytotoxicity by down-regulating thymidylate synthase in human cancer cells. 2006 Mol. Cancer Ther. pmid:17172411
Kozłowska A and Jagodziński PP Effect of Trichostatin A on CD4 surface density in peripheral blood T cells. 2006 Folia Histochem. Cytobiol. pmid:17219719
He J et al. Effects of trichostatin A on HDAC8 expression, proliferation and cell cycle of Molt-4 cells. 2006 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:17219959
Liu H et al. Trichostatin A regulates hGCN5 expression and cell cycle on Daudi cells in vitro. 2006 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:17219960
Sun C et al. Anticancer activities of trichostatin A on maligant lymphoid cells. 2006 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:17219961
Kim HR et al. Trichostatin A induces apoptosis in lung cancer cells via simultaneous activation of the death receptor-mediated and mitochondrial pathway? 2006 Exp. Mol. Med. pmid:17202837
Wang Q et al. Histone phosphorylation and pericentromeric histone modifications in oocyte meiosis. 2006 Cell Cycle pmid:16969090
Karvonen U et al. Androgen receptor regulates nuclear trafficking and nuclear domain residency of corepressor HDAC7 in a ligand-dependent fashion. 2006 Exp. Cell Res. pmid:16860317
Wagner S et al. SET-mediated promoter hypoacetylation is a prerequisite for coactivation of the estrogen-responsive pS2 gene by PRMT1. 2006 J. Biol. Chem. pmid:16861234
Zhang X et al. Histone deacetylase inhibitor, trichostatin A, increases the chemosensitivity of anticancer drugs in gastric cancer cell lines. 2006 Oncol. Rep. pmid:16865256
Villanueva R et al. Histone deacetylase 3 represses HTLV-1 tax transcription. 2006 Oncol. Rep. pmid:16865259
van den Boom J et al. Identification of novel genes associated with astrocytoma progression using suppression subtractive hybridization and real-time reverse transcription-polymerase chain reaction. 2006 Int. J. Cancer pmid:16865689
Bai J et al. Histone deacetylase inhibitor trichostatin A and proteasome inhibitor PS-341 synergistically induce apoptosis in pancreatic cancer cells. 2006 Biochem. Biophys. Res. Commun. pmid:16904634
Charrier C et al. Synthesis of rigid trichostatin A analogs as HDAC inhibitors. 2006 Bioorg. Med. Chem. Lett. pmid:16904890
Bell CW et al. The extracellular release of HMGB1 during apoptotic cell death. 2006 Am. J. Physiol., Cell Physiol. pmid:16855214
Olaharski AJ et al. The histone deacetylase inhibitor trichostatin a has genotoxic effects in human lymphoblasts in vitro. 2006 Toxicol. Sci. pmid:16857700
Lund P et al. Oncogenic HRAS suppresses clusterin expression through promoter hypermethylation. 2006 Oncogene pmid:16568090
Piacentini P et al. Trichostatin A enhances the response of chemotherapeutic agents in inhibiting pancreatic cancer cell proliferation. 2006 Virchows Arch. pmid:16568310
Alao JP et al. The cyclin D1 proto-oncogene is sequestered in the cytoplasm of mammalian cancer cell lines. 2006 Mol. Cancer pmid:16503970
Alao JP et al. Histone deacetylase inhibitor, trichostatin A induces ubiquitin-dependent cyclin D1 degradation in MCF-7 breast cancer cells. 2006 Mol. Cancer pmid:16504004
Ostapkowicz A et al. Lipid rafts remodeling in estrogen receptor-negative breast cancer is reversed by histone deacetylase inhibitor. 2006 Mol. Cancer Ther. pmid:16505096
Hellebrekers DM et al. Angiostatic activity of DNA methyltransferase inhibitors. 2006 Mol. Cancer Ther. pmid:16505122
Kong X et al. Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1alpha. 2006 Mol. Cell. Biol. pmid:16507982
Araki H et al. Expansion of human umbilical cord blood SCID-repopulating cells using chromatin-modifying agents. 2006 Exp. Hematol. pmid:16459182
Sonnemann J et al. Histone deacetylase inhibitors induce cell death and enhance the susceptibility to ionizing radiation, etoposide, and TRAIL in medulloblastoma cells. 2006 Int. J. Oncol. pmid:16465382
Pedram M et al. Telomere position effect and silencing of transgenes near telomeres in the mouse. 2006 Mol. Cell. Biol. pmid:16479005
Rybouchkin A et al. Role of histone acetylation in reprogramming of somatic nuclei following nuclear transfer. 2006 Biol. Reprod. pmid:16481594
Kwon HS et al. Retinoic acids and trichostatin A (TSA), a histone deacetylase inhibitor, induce human pyruvate dehydrogenase kinase 4 (PDK4) gene expression. 2006 Mar-Apr Biochim. Biophys. Acta pmid:16757381
Wu J et al. Diverse histone modifications on histone 3 lysine 9 and their relation to DNA methylation in specifying gene silencing. 2007 BMC Genomics pmid:17524140
Choy SW et al. C. elegans SIN-3 and its associated HDAC corepressor complex act as mediators of male sensory ray development. 2007 Biochem. Biophys. Res. Commun. pmid:17506990
Royo H et al. Bsr, a nuclear-retained RNA with monoallelic expression. 2007 Mol. Biol. Cell pmid:17507654
Roy S and Tenniswood M Site-specific acetylation of p53 directs selective transcription complex assembly. 2007 J. Biol. Chem. pmid:17121856
Snykers S et al. Chromatin remodeling agent trichostatin A: a key-factor in the hepatic differentiation of human mesenchymal stem cells derived of adult bone marrow. 2007 BMC Dev. Biol. pmid:17407549
Horion J et al. Histone deacetylase inhibitor trichostatin A sustains sodium pervanadate-induced NF-kappaB activation by delaying IkappaBalpha mRNA resynthesis: comparison with tumor necrosis factor alpha. 2007 J. Biol. Chem. pmid:17409387
Ryningen A et al. Clonogenic acute myelogenous leukemia cells are heterogeneous with regard to regulation of differentiation and effect of epigenetic pharmacological targeting. 2007 Leuk. Res. pmid:17416413
Khaw AK et al. Inhibition of telomerase activity and human telomerase reverse transcriptase gene expression by histone deacetylase inhibitor in human brain cancer cells. 2007 Mutat. Res. pmid:17669439
Ehrenkaufer GM et al. Trichostatin A effects on gene expression in the protozoan parasite Entamoeba histolytica. 2007 BMC Genomics pmid:17612405
Platta CS et al. The HDAC inhibitor trichostatin A inhibits growth of small cell lung cancer cells. 2007 J. Surg. Res. pmid:17612559
Mogal AP et al. Haploinsufficient prostate tumor suppression by Nkx3.1: a role for chromatin accessibility in dosage-sensitive gene regulation. 2007 J. Biol. Chem. pmid:17602165
Meng CF et al. Re-expression of methylation-induced tumor suppressor gene silencing is associated with the state of histone modification in gastric cancer cell lines. 2007 World J. Gastroenterol. pmid:18069755
Ferreira R et al. Site-specific acetylation of ISWI by GCN5. 2007 BMC Mol. Biol. pmid:17760996
Jamaluddin MD et al. Homocysteine inhibits endothelial cell growth via DNA hypomethylation of the cyclin A gene. 2007 Blood pmid:17698632
McCool KW et al. The role of histone acetylation in regulating early gene expression patterns during early embryonic stem cell differentiation. 2007 J. Biol. Chem. pmid:17204470
Bártová E et al. Differentiation-specific association of HP1alpha and HP1beta with chromocentres is correlated with clustering of TIF1beta at these sites. 2007 Histochem. Cell Biol. pmid:17205308
Kuang PP et al. Activation of elastin transcription by transforming growth factor-beta in human lung fibroblasts. 2007 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:17209135
Zhao TC et al. Inhibition of histone deacetylases triggers pharmacologic preconditioning effects against myocardial ischemic injury. 2007 Cardiovasc. Res. pmid:17884027
Liu T et al. Regulation of Cdx2 expression by promoter methylation, and effects of Cdx2 transfection on morphology and gene expression of human esophageal epithelial cells. 2007 Carcinogenesis pmid:16990345
Cao D et al. COX-2 expression induced by diesel particles involves chromatin modification and degradation of HDAC1. 2007 Am. J. Respir. Cell Mol. Biol. pmid:17395887
Li Y et al. Regulation of neuronal nitric oxide synthase exon 1f gene expression by nuclear factor-kappaB acetylation in human neuroblastoma cells. 2007 J. Neurochem. pmid:17250678
Terry-Allison T et al. Relaxed repression of herpes simplex virus type 1 genomes in Murine trigeminal neurons. 2007 J. Virol. pmid:17855552
Putnik J et al. The interaction of ETV6 (TEL) and TIP60 requires a functional histone acetyltransferase domain in TIP60. 2007 Biochim. Biophys. Acta pmid:17980166
Kuljaca S et al. Enhancing the anti-angiogenic action of histone deacetylase inhibitors. 2007 Mol. Cancer pmid:17958916